Overall verdict
Neutral
5.3/10
1-year performance
+8.09%
Score breakdown
Up 8.1% over 1 year, 44% of the 52-week range.
Strongest: Profitability 9.2/10. Weakest: Growth 1.4/10.
21 analysts, target +0.2% vs the price.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals.
It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand ; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand ; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand.
This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Sector
Consumer Staples
Industry
Household Products
Primary listing
Nyse
United States
CEO
Noel Wallace
Founded
1806
Employees
33 600
Revenue / employee
606 607 USD
Next earnings
October 30, 2026 (Q3 2026)
Institutional holders
- BlackRock, Inc.8.72%
- VANGUARD CAPITAL MANAGEMENT LLC6.52%
- STATE STREET CORP5.86%
- PRICE T ROWE ASSOCIATES INC /MD/3.48%
- VANGUARD PORTFOLIO MANAGEMENT LLC3.00%
- GEODE CAPITAL MANAGEMENT, LLC2.89%
- MORGAN STANLEY2.75%
- Bank of New York Mellon Corp1.69%
- DEUTSCHE BANK AG\1.47%
- Other institutions47.09%
- Rest of the register16.54%
2014 13F filings as of June 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
99.33 USD
52-week low
74.55 USD
1-year performance
8.09%
Rising
Year-to-date performance
8.87%
Rising
Drawdown
-13.98%
Mild pullback
Position in the 52-week range
44% of range
Against the world ETF
Over 17 years, from September 2009 to August 2026, the share did not do better than the world ETF once risk is accounted for. It earned less, while shaking 1.3 times harder.
10,000 € placed at the end of September 2009 are worth today
| Colgate-Palmolive | 44 203 € |
| World ETF | 74 620 € |
| S&P 500 | 123 025 € |
| Risk-free placement | 11 288 € |
The risk
- Shaking:the share moves 1.3 times as much as the world ETF.
- Worst fall:-32 % between September 2024 and October 2025. 10,000 € placed at the top fell to 6 808 €. The world ETF, at worst: -34 %. The share has not returned to its high yet.
Colgate-Palmolive earned less than the world ETF since 2009
Value of 10,000 euros placed at the end of September 2009, dividends reinvested, in euros
- Colgate-Palmolive: 44 203 €
- World ETF: 74 620 €
- S&P 500: 123 025 €
- Risk-free placement: 11 288 €
Based on past performance. This is not a recommendation.
Range: 87.00 USD - 105.48 USD (2 methods agree)
The price implies growth of 3.44% per year; the company grows at -3.47%.
Gross margin 60.4%, net margin 9.7%, ROIC 25.6%, ROE 434.3%.
Net margin
9.68%
Fair
Sector 8.17%|S&P 12.97%
Gross margin
60.42%
Exceptional
Return on equity (ROE)
434.33%
Exceptional
Sector 11.27%|S&P 16.52%
Return on invested capital (ROIC)
25.61%
Exceptional
Free cash flow margin (FCF)
18.33%
Exceptional
Profit-to-cash conversion (FCF conversion)
1.89x
Exceptional
Margin stability
2.2 pts
Steady
Revenue to net income
Growth
1.4/10Revenue up 4.9% over 1 year, 4.4% a year over 5, EPS -3.5% a year over 5.
Revenue (trailing 12 months)
21.0Md USD
Revenue growth (1y)
4.91%
Hyper-growth
Revenue growth (3y)
13.44%
Moderate
EPS growth (1y)
-5.40%
Declining
EPS CAGR (5y)
-3.47%
Declining
EPS revisions (3 months)
1.64%
Revised up
Valuation
2.2/10P/E 33.8x, forward P/E 23.2x, EV/EBITDA 19.8x. The multiple sits in the 52th percentile of its own 5-year history.
P/E (TTM)
33.8x
Expensive
Sector 17.0x|S&P 23.0x
Forward P/E
23.2x
Expensive
EV / EBITDA
19.8x
Expensive
Sector 10.0x|S&P 14.5x
PEG
—
Sector 0.79|S&P 0.86
Fair value (reverse DCF)
100.50 USD
Undervalued
P/E vs its own 5-year history
among the 48% highest valuations
In line with its history
Market cap
68.5Md USD
Financial strength
6.0/10Cash covers 18.5% of the debt, net debt/EBITDA 1.5x.
Net debt / EBITDA
1.5x
Solid
Gearing (net debt / equity)
1131.45%
Stretched
Cash
1.5Md USD
Cash / market cap
2.12%
Stretched
Cash / total debt
18.49%
Tight
Interest coverage
12.3x
Very solid
Net debt
6.4Md USD
Equity
566M USD
Closed daily candles, 2 years
Last close on September 24, 2026: 85.32 USD
- MM2088.15
- MM5090.40
- MM20088.24
- RSI 1434.1
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+1.13%
200-day average slope, 3 months
+4.38%
50-day average slope, 1 month
-1.61%
Price structure
higher-low
Bullish RSI divergence
No
20-day volatility
0.79 % per day
Volatility change
-44.49%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 3.68 (6) | 3.88 (20) | 21 402 (18) | 5 094 (14) | 2 841 (6) |
| 2027 | 3.94 (7) | 4.10 (20) | 22 073 (18) | 5 359 (14) | 3 119 (6) |
Amounts in millions of USD, EPS in USD per share. In brackets, the number of analysts. Consensus as of September 20, 2026.
Same sub-industry: 34 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HEN3 | 6.2 | 6.9 | 32.6Md USD | 15.8x | 9.4 % | — | 8.3 % | 0.2x | 7.1 % | 6.9 % | ||
| 2 | 8113 | 6.2 | 6.4 | 11.1Md USD | 25.6x | 6.7 % | 6.9 % | 8.1 % | -1.9x | 6.0 % | -2.5 % | ||
| 3 | RKT | 6.1 | 6.9 | 41.7Md USD | 11.3x | 21.2 % | 0.3 % | 22.4 % | 1.7x | 4.9 % | -12.9 % | ||
| 4 | CHD | 5.7 | 5.3 | 22.8Md USD | 30.9x | 12.0 % | 1.6 % | 11.1 % | 1.5x | 4.9 % | 9.7 % | ||
| 5 | PG | 5.7 | 5.5 | 342Md USD | 22.3x | 18.4 % | 1.5 % | 20.7 % | 1.0x | 4.4 % | -4.2 % | ||
| 6 | KMB | 5.5 | 5.2 | 32.5Md USD | 16.6x | 10.2 % | 0.6 % | 21.1 % | 2.1x | 5.6 % | -21.1 % | ||
| 7 | ESSITY B | 5.4 | 5.6 | 17.9Md USD | 14.8x | 8.8 % | 2.6 % | 10.2 % | 1.1x | 6.2 % | 8.3 % | ||
| 8 | CL | 5.3 | 4.6 | 68.5Md USD | 33.8x | 9.7 % | 4.9 % | 25.6 % | 1.5x | 5.6 % | 8.1 % | ||
| 9 | CLX | 4.3 | 4.4 | 10.2Md USD | 17.4x | 8.7 % | -2.0 % | 15.4 % | 4.8x | 4.0 % | -32.1 % |
